368 related articles for article (PubMed ID: 29642503)
1. Migration/Invasion of Malignant Gliomas and Implications for Therapeutic Treatment.
Liu CA; Chang CY; Hsueh KW; Su HL; Chiou TW; Lin SZ; Harn HJ
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642503
[TBL] [Abstract][Full Text] [Related]
2. Functional roles of enhancer of zeste homolog 2 in gliomas.
Yin Y; Qiu S; Peng Y
Gene; 2016 Jan; 576(1 Pt 2):189-94. PubMed ID: 26435191
[TBL] [Abstract][Full Text] [Related]
3. Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells.
Xu C; He T; Li Z; Liu H; Ding B
Biomed Pharmacother; 2017 Nov; 95():1504-1513. PubMed ID: 28946213
[TBL] [Abstract][Full Text] [Related]
4. si-PDGFR
Li Y; Yu H; Ma Q; Wei M; Liu X; Qi Y; Li C; Dong L; Zhang H
Oxid Med Cell Longev; 2022; 2022():5081439. PubMed ID: 36275907
[TBL] [Abstract][Full Text] [Related]
5. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H
Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571
[TBL] [Abstract][Full Text] [Related]
6. [Hedgehog signaling in the pathogenesis of neuro-oncology diseases].
Cherepanov SA; Baklaushev VP; Gabashvili AN; Shepeleva II; Chekhonin VP
Biomed Khim; 2015; 61(3):332-42. PubMed ID: 26215410
[TBL] [Abstract][Full Text] [Related]
7. EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.
Tao J; Shi L; Huang L; Shi H; Chen H; Wang Y; Wang T
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2211-2219. PubMed ID: 28748258
[TBL] [Abstract][Full Text] [Related]
8. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.
Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G
Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of tumor cell invasion and angiogenesis in the central nervous system.
Visted T; Enger PO; Lund-Johansen M; Bjerkvig R
Front Biosci; 2003 May; 8():e289-304. PubMed ID: 12700036
[TBL] [Abstract][Full Text] [Related]
10. The Expression of Cyclin D1, VEGF, EZH2, and H3K27me3 in Atypical Teratoid/Rhabdoid Tumors of the CNS: A Possible Role in Targeted Therapy.
Kakkar A; Biswas A; Goyal N; Suri V; Sharma MC; Gupta D; Julka PK; Sarkar C
Appl Immunohistochem Mol Morphol; 2016; 24(10):729-737. PubMed ID: 26469332
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of Fra1 expression by Wnt/β-catenin signalling promotes glioma aggressiveness through epithelial-mesenchymal transition.
Zhang L; Liu H; Mu X; Cui J; Peng Z
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28232512
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic modification in gliomas: role of the histone methyltransferase EZH2.
Bian EB; Li J; He XJ; Zong G; Jiang T; Li J; Zhao B
Expert Opin Ther Targets; 2014 Oct; 18(10):1197-206. PubMed ID: 25046371
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression.
Wang SH; Yang Y; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
Cancer Lett; 2016 Sep; 380(1):122-33. PubMed ID: 27345740
[TBL] [Abstract][Full Text] [Related]
15. Killing Glioma 'Stem-like' Cells via Drug-Induced Relocation of Endosomal Urokinase Proteins.
Gorin FA; Pasupuleti N; Mahajan D; Dugar S
Anticancer Agents Med Chem; 2017; 17(1):40-47. PubMed ID: 27357540
[TBL] [Abstract][Full Text] [Related]
16. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer.
Li Z; Hou P; Fan D; Dong M; Ma M; Li H; Yao R; Li Y; Wang G; Geng P; Mihretab A; Liu D; Zhang Y; Huang B; Lu J
Cell Death Differ; 2017 Jan; 24(1):59-71. PubMed ID: 27716745
[TBL] [Abstract][Full Text] [Related]
17. Pediatric high-grade glioma: current molecular landscape and therapeutic approaches.
Braunstein S; Raleigh D; Bindra R; Mueller S; Haas-Kogan D
J Neurooncol; 2017 Sep; 134(3):541-549. PubMed ID: 28357536
[TBL] [Abstract][Full Text] [Related]
18. Central Nervous System: Notable Developments in the Management of Primary and Recurrent Gliomas.
Nabors LB
J Natl Compr Canc Netw; 2016 May; 14(5 Suppl):681-4. PubMed ID: 27226514
[TBL] [Abstract][Full Text] [Related]
19. Advances in the molecular genetics of gliomas - implications for classification and therapy.
Reifenberger G; Wirsching HG; Knobbe-Thomsen CB; Weller M
Nat Rev Clin Oncol; 2017 Jul; 14(7):434-452. PubMed ID: 28031556
[TBL] [Abstract][Full Text] [Related]
20. Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors.
Sharma V; Purkait S; Takkar S; Malgulwar PB; Kumar A; Pathak P; Suri V; Sharma MC; Suri A; Kale SS; Kulshreshtha R; Sarkar C
Brain Tumor Pathol; 2016 Apr; 33(2):117-28. PubMed ID: 26746204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
